BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Autonomous University of Madrid

Headquarters: Madrid, Spain
Year Founded: 1968
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Jan 12, 2024
Discovery & Translation

Neutrophil reprogramming in tumors; plus Red Queen, Orbis platforms and more

BioCentury’s roundup of translational innovations
BioCentury | Dec 3, 2021
Distillery Therapeutics

A MERS-CoV RNA replicon vaccine candidate

BioCentury | Oct 1, 2021
Distillery Therapeutics

Oncolytic murine parvovirus therapy for glioblastoma

BioCentury | Sep 12, 2019
Distillery Therapeutics

SMPD1 gene therapy for Niemann-Pick disease type A

BioCentury | Aug 29, 2017
Distillery Therapeutics

Cancer

BioCentury | Jan 25, 2017
Distillery Therapeutics

Cardiovascular

BioCentury | Jun 23, 2016
Distillery Therapeutics

Therapeutics: Thyroid hormone receptor

BioCentury | Aug 21, 2014
Distillery Therapeutics

Indication: Neurology

BioCentury | Apr 21, 2014
Emerging Company Profile

Minoryx: Mediating rare metabolism

Minoryx's chaperones and repurposed drugs treat inherited metabolic diseases
Items per page:
1 - 10 of 14
Help Center
Username
Request Training
Submit Data Correction
Ask a Question